Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Research news

Obesity is associated with increased risk for psychiatric disorders

July 19, 2023

Leo Sher, M.D.

A research report, “Obesity as pleiotropic risk state for metabolic and mental health throughout life” has recently been published in Translational Psychiatry (1).

A significant part of the worldwide population is overweight. Obesity is a substantial global health burden. The prevalence rates of obesity have been progressively increasing over the past decades. Obesity is associated with metabolic syndrome, hypertension, and other medical conditions. Obesity is known to increase risk for and severity of psychiatric disorders.

A research group from the Medical University of Vienna examined the Austrian national registry data of inpatient services from 1997 to 2014 to study associations between a diagnosis of obesity and psychiatric disorders. Data covered about 45 million hospital stays of 9 million patients. Data were stratified by age decades and associations between each pair of diagnoses were computed with the Cochran-Mantel-Haenszel method, providing odds ratios (OR) and p values corrected for multiple testing. Directions of the associations were assessed by calculating time-order-ratios.

The authors found that across all age groups, obesity was associated with significantly elevated odds for a large spectrum of psychiatric disorders, including depression, psychosis-spectrum, anxiety, eating, and personality disorders. Researchers observed that for all co-diagnoses except for psychosis-spectrum, obesity was significantly more often the diagnosis received first, i.e., obesity commonly preceded psychiatric conditions. Significant sex differences were observed for most disorders, with women showing elevated risk for all disorders except schizophrenia and nicotine addiction. The authors suggest that among biological pathways linking obesity to mental illnesses, increased neuroinflammation due to cytokine production in adipocytes may be most prominent.

Among medical diagnoses, diabetes mellitus, arterial hypertension and dyslipidemia emerged as the strongest associations with obesity. This is consistent with the role of obesity as a major factor in metabolic dysregulation.

Reference

  1. Leutner M, Dervic E, Bellach L, Klimek P, Thurner S, Kautzky A. Obesity as pleiotropic risk state for metabolic and mental health throughout life. Transl Psychiatry. 2023 May 30;13(1):175. doi: 10.1038/s41398-023-02447-w.

Related Posts

Research news /

Age and antisuicidal effect of lithium

Research news /

The effect of multivitamin supplementation on memory in older adults

Research news /

Vitamin D serum levels, supplementation, and suicide attempts and intentional self-harm among Veterans

‹ Kratom – what ?: another widely available opioid… should it be ?… should it be regulated ?… what to do? › Intranasal esketamine ought to be more widely available

Editorials

  • Navigating ethical dilemmas in genetic testing for Huntington’s Disease
  • Loneliness: Surgeon General Dr. Murthy’s warning
  • Intranasal esketamine ought to be more widely available
  • Kratom – what ?: another widely available opioid… should it be ?… should it be regulated ?… what to do?

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Age and antisuicidal effect of lithium
  • Obesity is associated with increased risk for psychiatric disorders
  • The effect of multivitamin supplementation on memory in older adults
  • Vitamin D serum levels, supplementation, and suicide attempts and intentional self-harm among Veterans

Latest News

  • Suicide rates in the United States in 2022
  • Suicide rates in the United States in 2001-2021
  • Leading world experts on suicide. Expertscape, the January 9, 2023, report
  • Best universities in the world

Interviews with eminent psychiatrists

  • Interview with Professor Shih-Ku Lin
  • Interview with Professor Masahito Fushimi
  • Interview with Professor Maurizio Pompili
  • Interview with Professor Marco Sarchiapone

Ten Years Ago

  • Plasma testosterone levels in bipolar suicide attempters
  • Teaching medical professionals and trainees about suicide prevention
  • Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors
  • Treatment of suicide attempters with bipolar disorder: a randomized clinical trial

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2023 AVCalc LLC. All rights reserved worldwide.